-31.0%
MRNA vs INCY
+77.5%
-108.5%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | INCY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.1% | -1.1% | -1.3% |
| 7D | -12.7% | -5.2% | -7.5% | -8.6% |
| 30D | -20.7% | +1.0% | -21.7% | -21.4% |
| 3M | +46.3% | -9.9% | +56.2% | +59.8% |
| 6M | +305.2% | +18.1% | +287.2% | +271.0% |
| YTD | +561.2% | +16.1% | +545.2% | +508.2% |
| 1Y | +772.1% | +12.6% | +759.4% | +717.7% |
| 3Y | +147.0% | +109.5% | +37.4% | +32.7% |
| All | -31.0% | +77.5% | -108.5% | -63.6% |
Cumulative growth
Daily Returns
Daily percentage return beside INCY.
Daily Out/Under-Performance
Portfolio return minus INCY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × INCY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded INCY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling